News
TipRanks on MSN2d
Septerna Begins Phase 1 Trial for SEP-631
The latest announcement is out from Septerna, Inc. ( (SEPN) ).
(Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug discovery, today announced the dosing of the first participants in its Phase 1 ...
TipRanks on MSN2d
Septerna doses first participants in Phase 1 trial of SEP-631
Septerna (SEPN) announced the dosing of the first participants in its Phase 1 clinical trial of SEP-631, a selective oral small molecule ...
Between the 2nd and 4th November, a veritable who’s who of British industry will gather at the Eden Project in Boldeva, Cornwall for Anthropy 2022, the event’s second year. Over three days and ...
Find out all the key statistics for Zenas BioPharma, Inc. (ZBIO), including valuation measures, fiscal year financial statistics, trading record, share statistics and more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback